Metformin prolongs survival in a ND-CKD (Alport syndrome) mouse model, and is enhanced when combined with losartan (image)

Kumamoto University

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.